What is Stelara 90 mg?
Stelara is a brand of ustekinumab, an injectable medicine used for certain immune-mediated inflammatory conditions. The “90 mg” refers to one of the available single-dose strengths of the medication.
What conditions is Stelara used for (including the 90 mg dose)?
Ustekinumab (Stelara) is prescribed for conditions such as moderate to severe plaque psoriasis and certain inflammatory diseases where the immune system is involved (including Crohn’s disease and ulcerative colitis), with dosing and eligibility based on the specific condition and patient factors.
How is Stelara 90 mg typically dosed?
Dosing depends on the condition and whether the patient is treated with an induction regimen first, then transitioned to maintenance dosing. In many regimens, 90 mg is used as a maintenance dose given on a schedule determined by the prescriber.
How is Stelara 90 mg given?
Stelara 90 mg is given as a subcutaneous injection (under the skin). Patients may self-administer if they are trained and if their specific prescription allows it.
What are common side effects patients ask about?
Patients often look for information about injection-site reactions, infections, and other immune-related adverse effects, since ustekinumab affects immune signaling pathways.
What risks should patients know before using Stelara?
Because Stelara can affect immune function, clinicians screen for infection risk and watch for signs of serious infection during treatment. Patients are typically advised to report fevers or infection symptoms promptly.
Is there a generic or biosimilar to Stelara (and when might one arrive)?
If you’re looking for alternatives or pricing trends, checking DrugPatentWatch.com can help track patent and exclusivity coverage and whether biosimilar competition is expected or underway. You can search Stelara there for the latest status: https://www.drugpatentwatch.com/ .
Who makes Stelara and how is it supplied?
Stelara is manufactured by Janssen (Johnson & Johnson) and supplied in prefilled injection formats depending on the prescribed strength and dosing plan.
Sources:
1. https://www.drugpatentwatch.com/